Auteur K. MORPHETT

  Tris disponibles Ajouter le résultat à votre sélection

  Affiner la recherche

E-cigarettes: A framework for comparative history and policy [Addiction opinion and debate]

V. BERRIDGE ; A. L. FAIRCHILD ; K. MORPHETT ; C. GARTNER ; W. HALL ; R. BAYER | 2024
Dans Addiction (Vol.119, n°11, November 2024) Article : Périodique

BACKGROUND: England, Australia and the United States have approached the regulation of e-cigarettes in very different ways, yet all three countries have appealed to the concept of evidence as underpinning policy responses. We compared these poli[...]

Plus d'info

Ajouter à la sélection

Lien externe

How has the brain disease model of addiction contributed to tobacco control?

W. HALL ; C. GARTNER ; K. MORPHETT | 2023
Dans Drug and Alcohol Dependence (Vol.253, December 2023) Article : Périodique

Our paper evaluates the extent to which the brain disease model of addiction (BDMA) has contributed to reducing the prevalence of tobacco smoking and  tobacco-related harm over the past 20 years. We discuss the ways in which genetic and neurosci[...]

Plus d'info

Ajouter à la sélection

Lien externe

Medicalisation, smoking and e-cigarettes: evidence and implications

K. MORPHETT ; A. CARTER ; W. HALL ; C. GARTNER | 2017
Dans Tobacco Control (Vol.26, e2, December 2017) Article : Périodique

There is debate in the tobacco control literature about the value of a medical model in reducing smoking-related harm. The variety of medical treatments for smoking cessation has increased, health professionals are encouraged to use them to assi[...]

Plus d'info

Ajouter à la sélection

Public attitudes in Australia towards the claim that addiction is a (brain) disease

C. MEURK ; B. PARTRIDGE ; A. CARTER ; W. HALL ; K. MORPHETT ; J. LUCKE | 2014
Dans Drug and Alcohol Review (Vol.33, n°3, May 2014) Article : Périodique

Introduction and Aims: We investigated the Australian public's understandings of addiction to alcohol and heroin and the factors predicting support for the idea that these types of addiction are ‘diseases’ and specifically 'brain diseases'. De[...]

Plus d'info

Ajouter à la sélection

Systematic review and meta-analyses of cytisine to support tobacco cessation

C. PULJEVIC ; D. STJEPANOVIC ; I. MECIAR ; H. KANG ; G. CHAN ; K. MORPHETT ; H. BENDOTTI ; G. KUNWAR ; C. GARTNER | 2024
Dans Addiction (Vol.119, n°10, October 2024) Article : Périodique

BACKGROUND AND AIMS: Cytisine (also known as cytisinicline) is a low-cost partial agonist of nicotinic acetylcholine receptors used to assist tobacco cessation. We aimed to review the effectiveness of cytisine for tobacco cessation and the effec[...]

Plus d'info

Ajouter à la sélection

Lien externe